Jiangsu Hengrui Pharmaceuticals Co., Ltd. Stock: price and insider trades · Hong Kong

Jiangsu Hengrui Pharmaceuticals Co., Ltd. belongs to the Health Care sector. Filings by its managers are published through HKEX. In the past year (22 October 2025 to 22 October 2026), 8 filings came from 7 insiders.

The flow runs one way only: 6 sales, from 6 insiders, and no purchase. No amount is published for 6 filings, which the totals therefore leave out.

Between a trade and the moment it shows up on HKEX, the median delay is 8 days. That lag is the time during which only the insider knows about the trade. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning.

Across the 1,314 companies tracked on its exchange, the median is 4 filings; at 8 filings, this issuer sits above that mark. Since 2026, the database holds no purchases and 6 sales by insiders of the company.

Elsewhere in the same sector, our signals recently picked up insider purchases at UCB. Source: insider filings from HKEX. Past trades are no guide to future returns.